首頁 > 市場調查報告書 > 製藥

呼吸器

市場調查報告書

商品編碼

1578283

全球鎮咳藥物市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢與預測

Global Antitussive Drugs Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年09月01日 | 出版商:

Value Market Research | 英文 117 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

全球鎮咳藥市場需求預計將從2023年的149551萬美元達到2032年近237427萬美元的市場規模，2024-2032年研究期間複合年成長率為5.27%。

鎮咳藥是一類異質藥物，通常用於抑制呼吸系統疾病患者的乾咳。鎮咳藥物可以治療普通感冒、流感、過敏、花粉熱或其他呼吸系統疾病（如鼻竇炎、支氣管炎等）引起的各種症狀。它們要不是鴉片類藥物，就是鴉片類藥物，如福爾可定、可待因和右美沙芬。最常用的非處方鎮咳藥之一是右美沙芬，它相對安全。它們是口服的，有糖漿、片劑或蒸氣形式。這些藥物不適合長期使用，因為它們有濫用的風險，甚至可能導致成癮。

市場動態

大氣污染率高和全球人口中呼吸系統疾病的盛行率不斷上升是止咳藥市場成長的主要刺激因素。個人咳嗽的傳染性以及咳嗽是一個未被滿足的重大醫療需求將進一步推動市場成長。由於持續咳嗽會損害人們的生活品質，因此鎮咳藥物的需求將穩定成長。這些藥物的認知度提高和容易獲得將有利於市場成長。繼續研究生產廉價、有效且副作用最小的止咳藥將阻礙該市場的成長。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具也對全球鎮咳藥物市場的各個細分市場進行了包容性評估。鎮咳藥物產業的成長和趨勢為本研究提供了整體方法。

市場區隔

鎮咳藥物市場報告的這一部分提供了國家和區域層面細分市場的詳細資料，從而幫助策略師確定相應產品或服務的目標人群以及即將到來的機會。

按指示

疼痛
寒冷的
咳嗽
其他

按藥物類別

周邊作用藥物
中樞作用藥物
其他

按藥物分類

右美沙芬
苯佐那酯

依劑型分類

平板電腦
糖漿
其他

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲鎮咳藥物市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。鎮咳藥市場的主要參與者包括輝瑞公司、強生公司、賽諾菲公司、葛蘭素史克公司、默克公司、諾華國際公司、阿斯特捷利康公司、勃林格殷格翰國際有限公司、羅氏控股公司、拜耳公司、梯瓦製藥Pharmaceutical Industries Ltd.、Sun Pharmaceutical Industries Ltd.、Mylan NV、Cipla Ltd.、Reckitt Benckiser Group Plc、Perrigo Company Plc、Glenmark Pharmaceuticals Ltd. 本部分包含競爭格局的整體視圖，其中包括各種策略發展，例如關鍵技術併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

簡介 - 市場動態
市場促進因素
市場限制
機會
產業動態
波特五力分析
市場吸引力分析
- 按指標進行的市場吸引力分析
- 按藥品類別分類的市場吸引力分析
- 藥品市場吸引力分析
- 按劑型分類的市場吸引力分析
- 市場吸引力分析：按地區

第 4 章：價值鏈分析

價值鏈分析
原料分析
- 原料清單
- 原料廠商清單
- 主要原物料價格走勢
潛在買家名單
行銷管道
- 直效行銷
- 間接行銷
- 行銷通路發展趨勢

第 5 章：全球鎮咳藥物市場分析：依適應症分類

按指示概述
歷史和預測數據
按指標分析
疼痛
寒冷的
咳嗽
其他

第 6 章：全球鎮咳藥物市場分析：依藥物類別

按藥物類別概述
歷史和預測數據
按藥物類別分析
周邊作用藥物
中樞作用藥物
其他

第 7 章：全球鎮咳藥物市場分析：依藥物分類

按藥物概述
歷史和預測數據
按藥物分析
右美沙芬
苯佐那酯

第 8 章：全球鎮咳藥物市場分析：按劑型

按劑型概述
歷史和預測數據
按劑型分析
平板電腦
糖漿
其他

第 9 章：全球鎮咳藥物市場分析：依地理位置

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區按國家銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲按國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 10 章：鎮咳藥公司的競爭格局

鎮咳藥市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 11 章：公司簡介

頂級公司市佔率分析
市場集中度
Pfizer Inc.

公司概況
公司收入
產品
最新動態

Johnson & Johnson

公司概況
公司收入
產品
最新動態

Sanofi SA

公司概況
公司收入
產品
最新動態

GlaxoSmithKline Plc

公司概況
公司收入
產品
最新動態

Merck & Co. Inc.

公司概況
公司收入
產品
最新動態

Novartis International AG

公司概況
公司收入
產品
最新動態

AstraZeneca Plc

公司概況
公司收入
產品
最新動態

Boehringer Ingelheim International GmbH

公司概況
公司收入
產品
最新動態

Roche Holding AG

公司概況
公司收入
產品
最新動態

Bayer AG

公司概況
公司收入
產品
最新動態

Teva Pharmaceutical Industries Ltd.

公司概況
公司收入
產品
最新動態

Sun Pharmaceutical Industries Ltd.

公司概況
公司收入
產品
最新動態

Mylan NV

公司概況
公司收入
產品
最新動態

Cipla Ltd.

公司概況
公司收入
產品
最新動態

Reckitt Benckiser Group Plc

公司概況
公司收入
產品
最新動態

Perrigo Company Plc

公司概況
公司收入
產品
最新動態

Glenmark Pharmaceuticals Ltd

公司概況
公司收入
產品
最新動態

註 - 在公司概況中，財務詳細資訊和最新發展視情況而定，或對私人公司而言可能不包括在內

簡介目錄圖表

Product Code: VMR11213977

The global demand for Antitussive Drugs Market is presumed to reach the market size of nearly USD 2374.27 Million by 2032 from USD 1495.51 Million in 2023 with a CAGR of 5.27% under the study period 2024-2032.

Antitussive drugs are a class of heterogeneous medications generally used to suppress dry cough in patients suffering from respiratory disorders. Antitussive drugs can cure various symptoms caused by the common cold, flu, allergies, hay fever, or other breathing disorders like sinusitis, bronchitis, etc. These drugs reduce the urge to cough in patients by acting on the cough center in the brain. They are either opiates or opioids like pholcodine, codeine, and dextromethorphan. One of the most used over-the-counter antitussive drugs is Dextromethorphan, and it is relatively safe. They are taken orally and are available in the form of syrup, tablets, or vapor. These drugs are not suitable for long-term use since they risk abuse and may even cause addiction.

MARKET DYNAMICS

A high rate of atmospheric pollution and the growing prevalence of respiratory disorders among the global population is the central stimulant for the growth of the cough suppressants market. The contagious nature of individual coughs and cough being a significant unmet medical need will further propel market growth. The demand for antitussive drugs will see a steady increase since persistent cough can harm a person's quality of life. Rising awareness and easy availability of these drugs will benefit market growth. Continuing research to produce cheap, effective cough suppressants with minimal side effects will hinder this market's growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Antitussive Drugs. The growth and trends of Antitussive Drugs industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Antitussive Drugs market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Indication

Pain
Cold
Cough
Others

By Drug Class

Peripherally Acting Drugs
Centrally Acting Drugs
Others

By Drug

Dextromethorphan
Benzonatate

By Dosage Form

Tablets
Syrup
Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Antitussive Drugs market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Antitussive Drugs market include Pfizer Inc., Johnson & Johnson, Sanofi S.A., GlaxoSmithKline Plc, Merck & Co. Inc., Novartis International AG, AstraZeneca Plc, Boehringer Ingelheim International GmbH, Roche Holding AG, Bayer AG, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Mylan N.V., Cipla Ltd., Reckitt Benckiser Group Plc, Perrigo Company Plc, Glenmark Pharmaceuticals Ltd. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. ANTITUSSIVE DRUGS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Indication
- 3.7.2 Market Attractiveness Analysis By Drug Class
- 3.7.3 Market Attractiveness Analysis By Drug
- 3.7.4 Market Attractiveness Analysis By Dosage Form
- 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL ANTITUSSIVE DRUGS MARKET ANALYSIS BY INDICATION

5.1. Overview By Indication
5.2. Historical and Forecast Data
5.3. Analysis By Indication
5.4. Pain Historic and Forecast Sales By Regions
5.5. Cold Historic and Forecast Sales By Regions
5.6. Cough Historic and Forecast Sales By Regions
5.7. Others Historic and Forecast Sales By Regions

6. GLOBAL ANTITUSSIVE DRUGS MARKET ANALYSIS BY DRUG CLASS

6.1. Overview By Drug Class
6.2. Historical and Forecast Data
6.3. Analysis By Drug Class
6.4. Peripherally Acting Drugs Historic and Forecast Sales By Regions
6.5. Centrally Acting Drugs Historic and Forecast Sales By Regions
6.6. Others Historic and Forecast Sales By Regions

7. GLOBAL ANTITUSSIVE DRUGS MARKET ANALYSIS BY DRUG

7.1. Overview By Drug
7.2. Historical and Forecast Data
7.3. Analysis By Drug
7.4. Dextromethorphan Historic and Forecast Sales By Regions
7.5. Benzonatate Historic and Forecast Sales By Regions

8. GLOBAL ANTITUSSIVE DRUGS MARKET ANALYSIS BY DOSAGE FORM

8.1. Overview By Dosage Form
8.2. Historical and Forecast Data
8.3. Analysis By Dosage Form
8.4. Tablets Historic and Forecast Sales By Regions
8.5. Syrup Historic and Forecast Sales By Regions
8.6. Others Historic and Forecast Sales By Regions

9. GLOBAL ANTITUSSIVE DRUGS MARKET ANALYSIS BY GEOGRAPHY

9.1. Regional Outlook
9.2. Introduction
9.3. North America Sales Analysis
- 9.3.1 Overview, Historic and Forecast Data Sales Analysis
- 9.3.2 North America By Segment Sales Analysis
- 9.3.3 North America By Country Sales Analysis
- 9.3.4 United States Sales Analysis
- 9.3.5 Canada Sales Analysis
- 9.3.6 Mexico Sales Analysis
9.4. Europe Sales Analysis
- 9.4.1 Overview, Historic and Forecast Data Sales Analysis
- 9.4.2 Europe By Segment Sales Analysis
- 9.4.3 Europe By Country Sales Analysis
- 9.4.4 United Kingdom Sales Analysis
- 9.4.5 France Sales Analysis
- 9.4.6 Germany Sales Analysis
- 9.4.7 Italy Sales Analysis
- 9.4.8 Russia Sales Analysis
- 9.4.9 Rest Of Europe Sales Analysis
9.5. Asia Pacific Sales Analysis
- 9.5.1 Overview, Historic and Forecast Data Sales Analysis
- 9.5.2 Asia Pacific By Segment Sales Analysis
- 9.5.3 Asia Pacific By Country Sales Analysis
- 9.5.4 China Sales Analysis
- 9.5.5 India Sales Analysis
- 9.5.6 Japan Sales Analysis
- 9.5.7 South Korea Sales Analysis
- 9.5.8 Australia Sales Analysis
- 9.5.9 South East Asia Sales Analysis
- 9.5.10 Rest Of Asia Pacific Sales Analysis
9.6. Latin America Sales Analysis
- 9.6.1 Overview, Historic and Forecast Data Sales Analysis
- 9.6.2 Latin America By Segment Sales Analysis
- 9.6.3 Latin America By Country Sales Analysis
- 9.6.4 Brazil Sales Analysis
- 9.6.5 Argentina Sales Analysis
- 9.6.6 Peru Sales Analysis
- 9.6.7 Chile Sales Analysis
- 9.6.8 Rest of Latin America Sales Analysis
9.7. Middle East & Africa Sales Analysis
- 9.7.1 Overview, Historic and Forecast Data Sales Analysis
- 9.7.2 Middle East & Africa By Segment Sales Analysis
- 9.7.3 Middle East & Africa By Country Sales Analysis
- 9.7.4 Saudi Arabia Sales Analysis
- 9.7.5 UAE Sales Analysis
- 9.7.6 Israel Sales Analysis
- 9.7.7 South Africa Sales Analysis
- 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE ANTITUSSIVE DRUGS COMPANIES

10.1. Antitussive Drugs Market Competition
10.2. Partnership/Collaboration/Agreement
10.3. Merger And Acquisitions
10.4. New Product Launch
10.5. Other Developments

11. COMPANY PROFILES OF ANTITUSSIVE DRUGS INDUSTRY

11.1. Top Companies Market Share Analysis
11.2. Market Concentration Rate
11.3. Pfizer Inc.
- 11.3.1 Company Overview
- 11.3.2 Company Revenue
- 11.3.3 Products
- 11.3.4 Recent Developments
11.4. Johnson & Johnson
- 11.4.1 Company Overview
- 11.4.2 Company Revenue
- 11.4.3 Products
- 11.4.4 Recent Developments
11.5. Sanofi S.A.
- 11.5.1 Company Overview
- 11.5.2 Company Revenue
- 11.5.3 Products
- 11.5.4 Recent Developments
11.6. GlaxoSmithKline Plc
- 11.6.1 Company Overview
- 11.6.2 Company Revenue
- 11.6.3 Products
- 11.6.4 Recent Developments
11.7. Merck & Co. Inc.
- 11.7.1 Company Overview
- 11.7.2 Company Revenue
- 11.7.3 Products
- 11.7.4 Recent Developments
11.8. Novartis International AG
- 11.8.1 Company Overview
- 11.8.2 Company Revenue
- 11.8.3 Products
- 11.8.4 Recent Developments
11.9. AstraZeneca Plc
- 11.9.1 Company Overview
- 11.9.2 Company Revenue
- 11.9.3 Products
- 11.9.4 Recent Developments
11.10. Boehringer Ingelheim International GmbH
- 11.10.1 Company Overview
- 11.10.2 Company Revenue
- 11.10.3 Products
- 11.10.4 Recent Developments
11.11. Roche Holding AG
- 11.11.1 Company Overview
- 11.11.2 Company Revenue
- 11.11.3 Products
- 11.11.4 Recent Developments
11.12. Bayer AG
- 11.12.1 Company Overview
- 11.12.2 Company Revenue
- 11.12.3 Products
- 11.12.4 Recent Developments
11.13. Teva Pharmaceutical Industries Ltd.
- 11.13.1 Company Overview
- 11.13.2 Company Revenue
- 11.13.3 Products
- 11.13.4 Recent Developments
11.14. Sun Pharmaceutical Industries Ltd.
- 11.14.1 Company Overview
- 11.14.2 Company Revenue
- 11.14.3 Products
- 11.14.4 Recent Developments
11.15. Mylan N.V.
- 11.15.1 Company Overview
- 11.15.2 Company Revenue
- 11.15.3 Products
- 11.15.4 Recent Developments
11.16. Cipla Ltd.
- 11.16.1 Company Overview
- 11.16.2 Company Revenue
- 11.16.3 Products
- 11.16.4 Recent Developments
11.17. Reckitt Benckiser Group Plc
- 11.17.1 Company Overview
- 11.17.2 Company Revenue
- 11.17.3 Products
- 11.17.4 Recent Developments
11.18. Perrigo Company Plc
- 11.18.1 Company Overview
- 11.18.2 Company Revenue
- 11.18.3 Products
- 11.18.4 Recent Developments
11.19. Glenmark Pharmaceuticals Ltd
- 11.19.1 Company Overview
- 11.19.2 Company Revenue
- 11.19.3 Products
- 11.19.4 Recent Developments